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Objective: To assess the potential relationship between Kaposi’s sarcoma-associated herpesvirus (KSHV)
infection and type 2 diabetes mellitus (DM-2) in Xinjiang, China.
Methods: A case–control study of consecutively included DM-2 patients and normal controls was
conducted among the Uygur and Han populations in Xinjiang Uygur Autonomous Region, China. Blood
samples were collected and KSHV seroprevalence, antibody titers, and viral load were investigated.
Logistic regression analysis and multiple linear regression analysis were applied to explore determinants
of the main outcome measures.
Results: A total of 324 patients with DM-2 and 376 normal controls were included. The seroprevalence of
KSHV was 49.1% (95% conﬁdence interval (CI) 43.6–54.5%) for diabetic patients and 23.7% (95% CI 19.4–
28.0%) for the control group. After adjusting for variables of ethnicity, sex, body mass index, occupation,
educational level, marital status, age, and smoking and alcohol consumption habits, the association
between DM-2 and KSHV infection still existed (odds ratio (OR) 2.94, 95% CI 2.05–4.22), and the risk of
KSHV infection increased with glucose concentration (OR 1.35, 95% CI 1.21–1.51). KSHV was more likely to
express both the latent and lytic antigens in diabetic patients (latent: OR 3.27, 95% CI 2.25–4.75; lytic: OR
3.99, 95% CI 2.68–5.93). Antibody titers and viral load increased in patients with higher blood glucose
levels (p < 0.001).
Conclusions: Patients with DM-2 have an elevated risk of KSHV infection. Both antibody titers and viral
load increased with blood glucose levels.
© 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
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Introduction
Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as
human herpesvirus 8 (HHV-8), has been shown to be the etiological
agent of all clinical forms of Kaposi’s sarcoma (KS), primary effusion
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lymphoma (PEL), and the plasmablastic variant of multicentric
Castleman disease (MCD) (Cesarman et al., 1995; Soulier et al., 1995;
Whitby et al., 1995). The virus has been studied worldwide since its
discovery by Chang et al. in 1994 (Chang et al., 1994). According to
previous epidemiological studies, the prevalence of KSHV in the
general population varies geographically; it is high in Sub-Saharan
Africa, moderate in the Mediterranean region, and low in northern
Europe, Asia, and USA (Dukers and Rezza, 2003; Zhang and Wang,
2017). In China, the prevalence of KSHV also varies across different
regions. Xinjiang Uygur Autonomous Region has been regarded as an
epidemic area where KSHV prevalence is higher than in other regions
of China (Zhang et al., 2012). However, the risk factors associated
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with viral infection that may explain the regional disparity have not
yet been fully elucidated.
Previous studies have shown higher KSHV seroprevalence and
increased KS risk in HIV-infected, transplant, and other immunocompromised patients (Anderson et al., 2008; Goedert et al.,
2002; Uldrick and Whitby, 2011), indicating the signiﬁcant
inﬂuence of immunosuppression on the primary viral infection
and subsequent disease development. Diabetes mellitus (DM) is a
non-communicable disease diagnosed when there is a high
glucose level in the blood. Due to multiple factors, such as
suppression of immune defense, microangiopathy, and the
hyperglycemic environment, patients with DM are more vulnerable to infection and tend to experience increased mortality from
infectious diseases (Korbel et al., 2018; Zoppini et al., 2018). It has
been suggested that hepatitis B/C virus and tuberculosis
infections are more prevalent in diabetic patients (Ba-Essa
et al., 2016; Ronacher et al., 2015; Zhu et al., 2016). Furthermore,
increasing reports indicate that there is an association between
type 2 diabetes mellitus (DM-2) and KSHV infection or the
development of KS (Caselli et al., 2014; Ingianni et al., 2007;
Sobngwi et al., 2008), while the evidence is still limited. High
glucose-mediated signaling pathways are postulated to increase
susceptibility to KSHV infection through involvement in the
induction of KSHV lytic reactivation, although the detailed
molecular mechanisms have not yet been fully described (Chang
et al., 2017).
According to the International Diabetes Federation, nearly half a
billion people are currently living with diabetes. Low- and middleincome countries assume almost 80% of the diabetes burden
(International Diabetes Federation, 2017). DM-2, characterized by
insulin resistance and hyperglycemia, is the most prevalent
metabolic disorder in China (Zhu et al., 2016). There is an urgent
need to improve the prognosis of diabetic patients and reduce the
global burden of this chronic disease. To date, the association
between diabetes and infection with KSHV has not been well
documented. In this study, it was hypothesized that DM-2 might be
associated with KSHV infection and this hypothesis was tested in
Xinjiang Province, China where the prevalence of KSHV is high. The
current study appears to be the ﬁrst to explore the relationship
between DM-2 and KSHV infection in this population, and the
ﬁndings will contribute to enhanced awareness of KSHV infection
among diabetic patients.
Materials and methods
Study design and participants
The study was conducted from January 2014 to July 2015 in
Xinjiang Uygur Autonomous Region, China. All consecutive
patients of Han or Uygur ethnicity diagnosed with DM-2 according
to the 1999 World Health Organization diagnostic criteria (World
Health Organization, 2006) were included. Patients without
diabetes in the same region were recruited as controls. Exclusion
criteria were (1) not Han or Uygur, and (2) diagnosed with type 1
diabetes. Demographic and clinical data were obtained from the
medical records. All study participants provided written informed
consent.
Blood collection
Blood samples were collected from participants using disposable sterile needles and ethylenediaminetetraacetic acid (EDTA)
tubes by professional nurses. Sera were separated and stored at
80  C for serological testing. All specimens were anonymized and
coded with unique identiﬁcation numbers.

Serological testing
KSHV seropositivity was determined by the presence of antiKSHV antibodies detected by immunoﬂuorescence assay (IFA) in
the serum samples of the study participants. All samples were
conﬁrmed using two IFAs, as described previously (Zheng et al.,
2017). First, a monoclonal-enhanced IFA (mIFA) (Minhas et al.,
2008) was applied to test the 1:40 phosphate buffered saline (PBS)
diluted serum samples. In brief, sera were incubated with BC3 cells
ﬁxed on glass microscopy slides. The specimens of KS patients and
healthy individuals were used as positive and negative controls.
Mouse monoclonal anti-human IgG (CRL-1786; American Type
Culture Collection, Manassas, VA, USA) was used as secondary
antibody and DyLight488-conjugated donkey anti-mouse IgG
(Jackson ImmunoResearch, West Grove, PA, USA) was employed
as the ﬂuorescent marker. The slides were examined by
epiﬂuorescence microscopy (Nikon, Japan). A negative ﬂuorescence reaction is indicated by the appearance of only red cells,
while bright apple-green ﬂuorescence indicates the presence of
anti-KSHV antibodies in the sample. Second, Spodoptera frugiperda
clone 9 cells infected with baculovirus expressing ORF65, ORF-K8.1
(lytic antigens) and ORF73 (latent nucleic antigen, LANA) were
coated on the slides and used for further testing (Fu et al., 2009). A
sample was considered seropositive only if it was positive with
both assays. The levels of antibodies were analyzed by performing
dilutions of the serum samples and were reported as titers.
Determination of viral load
A TaqMan Real-Time PCR assay was conducted to quantitate the
number of KSHV genomic copies in DNA samples of IFA-positive
participants after nested PCR ampliﬁcation of ORF26 and gB.
Human β-globin and KSHV ORF26 were ampliﬁed using primers
and probes described previously (Olp et al., 2013). Each 25 ml
reaction mixture contained the following: 5 ml sample and 20 ml
PCR mixture consisting of 12.5 ml Universal PCR Master Mix (PE
Applied Biosystems) and primers and probe at concentration of
200 nM, respectively. The Master Mix contained uracil-N-glycosylase, which eliminated previously ampliﬁed PCR products to
protect against carryover contamination. Ampliﬁcation conditions
were 50  C for 2 min, 95  C for 10 min, and 40 cycles of 95  C for 15 s
and 60  C for 1 min. All samples were run in triplicate and the mean
KSHV copy number per cellular equivalent was calculated.
Statistical analysis
Both laboratory test results and medical records were doubleentered and managed in EpiData 3.1. All data were subsequently
transferred to SAS 9.4 (SAS Institute, Inc., Cary, NC, USA) and
GraphPad Prism 7.0 (GraphPad, La Jolla, CA, USA) for further
statistical analysis. Continuous variables were expressed as the
mean  standard deviation or median and interquartile range (IQR)
according to the statistical distribution. Categorical variables were
described as numbers or proportions. A non-parametric test
(Mann–Whitney U-test) was used to assess the difference in
geometric mean titers (GMT) of KSHV antibodies and medians of
viral load between different groups. Logistic regression analysis
was applied to examine the risk factors for KSHV seropositivity.
Multiple linear regression analysis was conducted to determine
whether a variable was associated with the KSHV antibody titer or
viral DNA load. The correlation with antibody titers and viral DNA
load was further assessed by Spearman’s rank correlation
coefﬁcient and simple linear regression. Ninety-ﬁve percent
conﬁdence intervals (95% CI) were calculated for all of the
coefﬁcients of regression. A two-sided p-value of <0.05 was
considered statistically signiﬁcant.
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control group. This difference was also statistically signiﬁcant
(Mann–Whitney U-test = 1490, p < 0.001) (Figure 1b).

Results
Participant characteristics

Risk factors of KSHV infection markers
A total of 324 patients with DM-2 and 376 normal controls were
included in this study. Sociodemographic and clinical characteristics of the participants, including ethnicity, sex, body mass index
(BMI), occupation, educational level, marital status, smoking and
alcohol consumption habits, age, and blood glucose concentration,
are described in Table 1. Speciﬁcally, the diabetes group had a
slightly higher percentage of Uygur (51.2%, 166/324) and male
(59.6%, 193/324) participants than the control group. The median
age was 53 (IQR 41–64) years in the diabetes group and 49 (IQR 37–
62) years in the control group. Among the patients with diabetes,
the median blood glucose concentration was 7.2 (IQR 6.5–8.0)
mmol/l; the value was 5.3 (4.4–5.8) mmol/l among normal
controls.
The distribution of KSHV antibody titers and viral load in the
participants
According to the IFA test results, the seroprevalence of KSHV
was 49.1% (95% CI 43.6–54.5%) in the DM-2 group and 23.7% (95% CI
19.4–28.0%) in the control group. The GMT of antibodies against
KSHV was 246.4 (95% CI 208.2–291.5) for diabetic patients and
105.9 (95% CI 85.3–131.5) for controls. A signiﬁcant difference in
the GMT of KSHV antibody titers was detected between the two
groups (Mann–Whitney U-test = 4008, p < 0.001) (Figure 1a). The
average viral load was 0.540 (IQR 0.129–0.832) copies/103 cells in
the DM-2 group and 0.063 (IQR 0.043–0.085) copies/103 cells in the

Table 1
Characteristics of study subjects with and without type 2 diabetes mellitus.
DM-2
324 (46.3)
Total number (%)
Ethnicity, n (%)
Han
158 (48.8)
Uygur
166 (51.2)
Sex, n (%)
Male
193 (59.6)
Female
131 (40.4)
BMI (kg/m2), n (%)
<18
21 (6.5)
18–24
185 (57.1)
>24
118 (36.4)
Occupation, n (%)
Student
12 (3.7)
Cadre
60 (18.5)
Worker
48 (14.8)
Farmer
77 (23.8)
Retired
97 (29.9)
None
30 (9.3)
Educational level, n (%)
Elementary school or lower
56 (17.3)
Middle school
79 (24.4)
High school
104 (32.1)
College or higher
85 (26.2)
Marital status, n (%)
Single
22 (6.8)
Married
265 (81.8)
Widowed/divorced
37 (11.4)
Ever smoker, n (%)
Yes
174 (53.7)
No
150 (46.3)
Regular alcohol consumption, n (%)
Yes
168 (51.9)
No
156 (48.2)
Age (years), median (IQR)
53 (41–64)
Glucose (mmol/l), median (IQR) 7.2 (6.5–8.0)

Control

Total

376 (53.7)

700 (100.0)

215 (57.2)
161 (42.8)

373 (53.3)
327 (46.7)

171 (45.5)
205 (54.5)

364 (52.0)
336 (48.0)

31 (8.2)
305 (81.1)
40 (10.6)

52 (7.4)
490 (70.0)
158 (22.6)

8 (2.1)
98 (26.1)
82 (21.8)
59 (15.7)
87 (23.1)
42 (11.2)

20 (2.9)
158 (22.6)
130 (18.6)
136 (19.4)
184 (26.3)
72 (10.3)

37 (9.8)
72 (19.2)
127 (33.8)
140 (37.2)

93 (13.3)
151 (21.6)
231 (33.0)
225 (32.1)

24 (6.4)
285 (75.8)
67 (17.8)

46 (6.6)
550 (78.6)
104 (14.9)

133 (35.4)
243 (64.6)

307 (43.9)
393 (56.1)

154 (41.0)
222 (59.0)
49 (37–62)
5.3 (4.4–5.8)

322 (46.0)
378 (54.0)
51 (39–63)
6.0 (5.1–7.1)

DM-2, type 2 diabetes mellitus; BMI, body mass index; IQR, interquartile range.

Infection with KSHV was found to be signiﬁcantly associated
with the following variables on univariate logistic regression
analysis (Table 2): (1) ethnicity (Uyghur vs. Han: odds ratio (OR)
1.50, 95% CI 1.10–2.05), (2) BMI (18–24 vs. <18 kg/m2: OR 0.55, 95%
CI 0.31–0.97), (3) occupation (student vs. none: OR 6.66, 95% CI
2.02–22.01), (4) educational level (college or higher vs. elementary
school or lower: OR 0.54, 95% CI 0.33–0.89), (5) marital status
(married vs. single: OR 0.41, 95% CI 0.22–0.75; widowed/divorced
vs. single: OR 0.33, 95% CI 0.16–0.67), (6) DM-2 (OR 3.11, 95% CI
2.25–4.29), and (7) glucose (mmol/l) (OR 1.35, 95% CI 1.22–1.50).
After adjusting for variables of ethnicity, sex, BMI, occupation,
educational level, marital status, smoking and alcohol consumption habits, age, and diabetic status in model 1, only the association
between DM-2 and KSHV infection remained signiﬁcant (OR 2.94,
95% CI 2.05–4.22). To avoid multicollinearity, diabetic status was
replaced with blood glucose level in model 2 and the risk of
infection was found to increase with glucose concentration (OR
1.35, 95% CI 1.21–1.51). Being a student was also shown to be a risk
factor (OR 7.53, 95% CI 1.43–39.58), although the conﬁdence
interval was wide.
The seropositivity rate of antibodies to ORF73, ORF65, and ORFK8.1 was 92.7% (230/248), 56.0% (139/248), and 45.6% (113/248),
respectively, in the IFA-positive participants. A total of 175 serum
samples tested positive for antibodies to both latent (ORF73) and
lytic (ORF65 or ORF-K8.1) antigens. Thus, 76.1% (175/230) of sera
that were positive for latent antibodies were also positive for lytic
antibodies. In contrast, 90.7% (175/193) of sera positive for lytic
antibodies were also positive for latent antibodies. It was found
that the virus was more likely to express both the latent and lytic
antigens in diabetic patients (latent: OR 3.27, 95% CI 2.25–4.75;
lytic: OR 3.99, 95% CI 2.68–5.93). In addition, Uygur ethnicity
appeared to be a risk factor for ORF73 antibody seroconversion (OR
1.48, 95% CI 1.01–2.16) (Table 3).
Correlation between KSHV viral load and antibody titers, and
correlates
Antibody titers and viral DNA load were tested for the 248 IFApositive participants. By multiple linear regression analysis
(Table 4), it was found that KSHV antibody titers were increased
in Uygur participants (p < 0.001), while the Han population had a
higher viral load level (p < 0.001). Furthermore, both antibody
titers and viral load increased in patients with higher blood glucose
levels (p < 0.001).
A further pairwise comparison between the logarithmic
transformation of KSHV antibody titers and viral load (copies/
103 cells) revealed a linear relationship (slope = 0.08, 95% CI 0.05–
0.11), with a signiﬁcant Spearman’s rank correlation (r = 0.34,
p < 0.001) (Figure 2).
Discussion
The prevalence of diabetes is increasing remarkably in low- and
middle-income countries, especially in the Southeast Asia and
Western Paciﬁc regions. China alone has a diabetic population of
approximately 121 million. Patients from these areas develop
disease earlier and suffer a worse prognosis than their counterparts in wealthier countries (International Diabetes Federation,
2017). It is therefore imperative that we learn more about the
potential complications of diabetes and improve medical care for
these patients. As the etiological agent of several tumors including
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Figure 1. (a) Titer distribution of Kaposi’s sarcoma-associated herpesvirus (KSHV) among patients with type 2 diabetes mellitus (DM-2) and normal controls. (b) Distribution
of viral load across the DM-2 and control groups.

Table 2
Unadjusted and adjusted analysis of risk factors associated with Kaposi’s sarcoma-associated herpesvirus infection according to immunoﬂuorescence assay results (n = 700).
Unadjusted

Ethnicity
Han
Uygur
Sex
Male
Female
BMI (kg/m2)
<18
18–24
>24
Occupation
None
Student
Cadre
Worker
Farmer
Retired
Educational level
Elementary school or lower
Middle school
High school
College or higher
Marital status
Single
Married
Widowed/divorced
Ever smoker
No
Yes
Regular alcohol consumption
No
Yes
DM-2
No
Yes
Age (years)
Glucose (mmol/l)

Adjusted (model 1)

Adjusted (model 2)

OR (95% CI)

p-Value

OR (95% CI)

p-Value

OR (95% CI)

p-Value

1.00
1.50 (1.10, 2.05)

0.011

1.00
1.42 (0.98, 2.06)

0.062

1.00
1.42 (0.98, 2.05)

0.064

1.00
0.78 (0.57, 1.06)

0.113

1.00
0.81 (0.50, 1.31)

0.386

1.00
0.78 (0.49, 1.27)

0.321

1.00
0.55 (0.31, 0.97)
0.88 (0.47, 1.65)

0.039
0.695

1.00
0.99 (0.44, 2.20)
0.98 (0.41, 2.34)

0.971
0.956

1.00
0.97 (0.43, 2.16)
0.94 (0.39, 2.26)

0.932
0.893

1.00
6.66 (2.02, 22.01)
0.69 (0.38, 1.23)
0.66 (0.36, 1.22)
1.03 (0.57, 1.86)
1.02 (0.58, 1.80)

0.002
0.206
0.187
0.917
0.936

1.00
5.21 (0.98, 27.66)
1.05 (0.42, 2.66)
0.53 (0.24, 1.20)
0.78 (0.40, 1.52)
0.96 (0.45, 2.05)

0.053
0.911
0.129
0.458
0.919

1.00
7.53 (1.43, 39.58)
1.35 (0.54, 3.38)
0.65 (0.29, 1.45)
0.91 (0.47, 1.79)
1.09 (0.51, 2.31)

0.017
0.525
0.294
0.792
0.829

1.00
0.79 (0.47, 1.35)
0.90 (0.55, 1.47)
0.54 (0.33, 0.89)

0.391
0.673
0.016

1.00
1.00 (0.53, 1.89)
1.44 (0.70, 2.94)
0.63 (0.26, 1.50)

0.994
0.319
0.293

1.00
0.97 (0.51, 1.85)
1.45 (0.71, 2.97)
0.57 (0.24, 1.37)

0.929
0.311
0.210

1.00
0.41 (0.22, 0.75)
0.33 (0.16, 0.67)

0.004
0.002

1.00
0.75 (0.30, 1.88)
0.60 (0.21, 1.67)

0.535
0.326

1.00
0.73 (0.29, 1.84)
0.54 (0.19, 1.49)

0.510
0.232

1.00
1.14 (0.84, 1.56)

0.405

1.00
0.88 (0.57, 1.33)

0.534

1.00
0.90 (0.59, 1.37)

0.617

1.00
1.10 (0.81, 1.51)

0.534

1.00
0.94 (0.63, 1.39)

0.741

1.00
0.92 (0.62, 1.37)

0.686

1.00
3.11 (2.25, 4.29)
1.00 (0.99, 1.01)
1.35 (1.22, 1.50)

<0.001
0.947
<0.001

1.00
2.94 (2.05, 4.22)
1.00 (0.98, 1.02)
–

<0.001
0.848
–

–
–
1.00 (0.98, 1.02)
1.35 (1.21, 1.51)

–
–
0.987
<0.001

OR, odds ratio; CI, conﬁdence interval; BMI, body mass index; DM-2, type 2 diabetes mellitus.

KS, PEL, and MCD, KSHV is also prevalent in these less developed
regions with a heavier diabetes burden. The present research
appears to be one of the largest studies in China to investigate the
relationship between KSHV infection and DM-2.
According to a previous meta-analysis (Zhang et al., 2012), the
pooled prevalence of KSHV was 11.3% (95% CI 7.2–15.5%) for the

general population and 22.2% (95% CI 12.7–31.8%) for immunocompromised patients in China. The KSHV prevalence varied in
different areas and was higher in the Xinjiang Uygur Autonomous
Region (i.e., 21.2% among the general population and 25.6% among
immunocompromised persons). In the present study of 324
patients and 376 normal controls from this region, the

M. Cui et al. / International Journal of Infectious Diseases 80 (2019) 73–79

77

Table 3
Risk factors for Kaposi’s sarcoma-associated herpesvirus infection markers (latent antigen: ORF73; lytic antigens: ORF65, ORF-K8.1) (n = 700).
Latent antigen

Ethnicity
Han
Uygur
Sex
Male
Female
BMI (kg/m2)
<18
18–24
>24
Occupation
None
Student
Cadre
Worker
Farmer
Retired
Educational level
Elementary school or lower
Middle school
High school
College or higher
Marital status
Single
Married
Widowed/divorced
Ever smoker
No
Yes
Regular alcohol consumption
No
Yes
DM-2
No
Yes
Age (years)

Lytic antigens

OR (95% CI)

p-Value

OR (95% CI)

p-Value

1.00
1.48 (1.01, 2.16)

0.043

1.00
1.27 (0.85, 1.90)

0.243

1.00
0.74 (0.45, 1.22)

0.241

1.00
0.65 (0.38, 1.11)

0.115

1.00
0.89 (0.39, 2.01)
0.88 (0.36, 2.14)

0.777
0.783

1.00
0.69 (0.29, 1.61)
0.79 (0.31, 1.97)

0.388
0.606

1.00
4.03
0.94
0.46
0.71
0.80

0.106
0.894
0.067
0.328
0.575

1.00
2.52
0.69
0.48
0.56
0.95

0.271
0.469
0.097
0.111
0.902

1.00
0.92 (0.48, 1.76)
1.29 (0.62, 2.67)
0.57 (0.23, 1.41)

0.802
0.490
0.223

1.00
1.21 (0.62, 2.39)
1.35 (0.64, 2.88)
0.74 (0.30, 1.83)

0.578
0.433
0.509

1.00
0.71 (0.28, 1.81)
0.60 (0.21, 1.70)

0.473
0.335

1.00
0.94 (0.34, 2.65)
0.84 (0.27, 2.65)

0.911
0.768

1.00
0.85 (0.55, 1.30)

0.446

1.00
0.94 (0.59, 1.48)

0.782

1.00
0.89 (0.59, 1.34)

0.577

1.00
0.87 (0.57, 1.34)

0.534

1.00
3.27 (2.25, 4.75)
1.00 (0.98, 1.01)

<0.001
0.567

1.00
3.99 (2.68, 5.93)
0.99 (0.98, 1.01)

<0.001
0.571

(0.75, 21.80)
(0.36, 2.42)
(0.20, 1.06)
(0.36, 1.40)
(0.37, 1.74)

(0.49, 13.14)
(0.26, 1.87)
(0.20, 1.14)
(0.27, 1.15)
(0.43, 2.12)

OR, odds ratio; CI, conﬁdence interval; BMI, body mass index; DM-2, type 2 diabetes mellitus.

seroprevalence of KSHV was found to be 23.7% (95% CI 19.4–28.0%)
for the control group and 49.1% (95% CI 43.6–54.5%) for DM-2
patients, which is generally consistent with the previous study
results. In addition, a strong association was conﬁrmed between
DM-2 and KSHV infection (OR 2.94, 95% CI 2.05–4.22) in the Han
and Uygur populations in Xinjiang Province, China. The results
were also strengthened by the observation of increased antibody
titers and viral DNA load in participants with higher blood glucose
levels. These ﬁndings are generally in agreement with those of
recent studies on KSHV infection among diabetic patients from
European and African countries (Caselli et al., 2014; Ingianni et al.,
2007; Piras et al., 2017; Sobngwi et al., 2008). In addition, it was
found that ethnicity might be inversely associated with the level of
antibody titers and viral load: the Uygur population had increased
antibody titer levels, while the viral DNA load was higher in the
Han population. The underlying mechanism is worth further study.
It is speculated that the discrepancy in immunological responses to
the virus among the two populations might be due in part to
different genetic composition related to the immune system, such
as the human leukocyte antigen (HLA) gene complex, as reported
previously (Alkharsah et al., 2007; Guech-Ongey et al., 2010).
Moreover, it was found that the expression of both latent (OR
3.27, 95% CI 2.25–4.75) and lytic (OR 3.99, 95% CI 2.68–5.93)
antigens was signiﬁcantly higher among patients with DM-2.
Combined with the observation of a positive correlation between
KSHV antibody titers and viral load (r = 0.34, p < 0.001), it could be
inferred that the virus is more likely to be reactivated and replicate
in higher glucose conditions. Therefore, diabetic patients are at

higher risk of KS and other KSHV-associated tumors (Anderson
et al., 2008; Chang et al., 2017). Although the study results conﬂict
with those of a study by Piras et al. (Piras et al., 2017), this
observation is supported by other studies that have shown that
high glucose levels can signiﬁcantly increase lytic reactivation of
KSHV. Multiple signaling pathways involved in the lifecycle of
KSHV have been proven to be modulated by high glucose in various
cell types (Chang et al., 2017; Ye et al., 2016).
Nevertheless, as a result of the case–control design of this
study, it was not possible to determine whether KSHV infection
preceded the onset of diabetes or not. Therefore, the causal
relationship between KSHV infection and DM-2 remains unresolved. It was not possible to determine whether diabetes
increases susceptibility to KSHV infection by reducing the
efﬁciency of the immune system, or, in contrast, whether the
metabolism of the infecting virus modiﬁes the microenvironment
thus leading to the onset of DM-2 (Piras et al., 2017). These two
hypotheses have both been supported by previous studies. Using
in vitro models, Chang et al. (Chang et al., 2017) found that high
glucose signiﬁcantly enhanced the susceptibility of various target
cells to KSHV infection by elevating the levels of speciﬁc cellular
receptors for KSHV entry, including integrin α3β1 and xCT/CD98.
In contrast, other studies have suggested that the onset of
diabetes may be partly due to the activity of KSHV, including
cytokine secretion, altering the metabolic pathways related to
insulin resistance, as with other chronic viral infections (Aytug
et al., 2003; Guillen et al., 2015; Mehta et al., 2003). An alternative
theory is that direct infection could induce endoplasmic
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Table 4
Multiple linear regression analysis of the Kaposi’s sarcoma-associated herpesvirus antibody titers and viral load among the immunoﬂuorescence assay-positive population
(n = 248).
KSHV antibody titersa

Ethnicity
Uygur vs. Han
Gender
Female vs. male
BMI (kg/m2)
18–24 vs. <18
>24 vs. <18
Occupation
Students vs. none
Cadre vs. none
Workers vs. none
Farmers vs. none
Retired vs. none
Educational level
Middle school vs. elementary school or lower
High school vs. elementary school or lower
College or higher vs. elementary school or lower
Marital status
Married vs. single
Widowed/divorced vs. single
Ever smoker
Yes vs. no
Regular alcohol consumption
Yes vs. no
Age (years)
Glucose (mmol/l)

Viral loadb

β (95% CI)

p-Value

1.03 (0.64, 1.42)

<0.001

0.15 ( 0.23,

0.104

0.02 ( 0.13, 0.09)

0.753

0.18 ( 0.63, 1.00)
0.14 ( 0.74, 1.02)

0.654
0.749

0.15 ( 0.32, 0.01)
0.07 ( 0.25, 0.11)

0.073
0.457

0.32 ( 1.76, 1.12)
0.25 ( 0.68, 1.19)
0.30 ( 0.53, 1.14)
0.19 ( 0.88, 0.51)
0.23 ( 0.52, 0.97)

0.661
0.593
0.475
0.598
0.549

0.04
0.01 (
0.04 (
0.01 (
0.02 (

( 0.34, 0.26)
0.18, 0.21)
0.14, 0.21)
0.13, 0.15)
0.14, 0.17)

0.809
0.891
0.667
0.895
0.847

0.41 ( 1.06, 0.24)
0.57 ( 1.27, 0.12)
0.86 ( 1.70, 0.03)

0.212
0.104
0.044

0.00 ( 0.13, 0.14)
0.04 ( 0.11, 0.18)
0.03 ( 0.20, 0.14)

0.947
0.599
0.724

0.57 ( 1.52, 0.38)
0.76 ( 1.85, 0.33)

0.241
0.169

0.09 ( 0.28, 0.11)
0.03 ( 0.25, 0.20)

0.382
0.826

0.38 ( 0.84, 0.08)

0.107

0.07 ( 0.16, 0.03)

0.177

0.43 ( 0.95, 0.09)

0.18 ( 0.23, 0.60)
0.00 ( 0.01, 0.02)
0.24 (0.17, 0.31)

0.377
0.634
<0.001

β (95% CI)

p-Value
0.07)

0.01 ( 0.09, 0.08)
0.00 (0, 00, 0.00)
0.10 (0.08, 0.11)

<0.001

0.836
0.701
<0.001

CI, conﬁdence interval; BMI, body mass index.
a
After log2 transformation.
b
Copies/103 cells.

Figure 2. Correlation between Kaposi’s sarcoma-associated herpesvirus (KSHV) antibody titers (after logarithmic transformation) and viral load (copies/103 cells) among the
immunoﬂuorescence assay-positive population (n = 248).

reticulum stress in pancreatic β-cells, affecting their functions
(Sobngwi et al., 2008). In the study by Lontchi-Yimagou et al., a
signiﬁcantly lower HOMA-β level was found in KSHV-DNApositive diabetic patients compared with the KSHV-DNA-negative group, while no difference was observed between patients
with and without KSHV antibodies. Thus, they proposed that
impaired insulin secretion might be associated with the replication of the virus (Lontchi-Yimagou et al., 2018). However, most of

the studies with a cross-sectional design have not provided the
time at which patients acquired diabetes and the viral infection.
In addition, the level of insulin secretion and insulin resistance as
speciﬁc biomarkers for diabetic patients should also be taken into
account in future studies. Therefore, there is a need for additional
well-designed prospective epidemiological cohort studies with a
large sample size to elucidate whether KSHV predisposes to DM-2
or vice versa.
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In conclusion, this study proposes an association between
DM-2 and KSHV infection in the Chinese Han and Uygur
populations, adding to the previously reported ﬁndings that
have mainly been observed in European and African countries.
Given the fact that diabetes poses a heavy disease burden in
China, the prevention of viral infection and development of
related diseases is imperative. More well-designed longitudinal
prospective cohort studies and biomedical research are warranted to better our understanding of the detailed pathophysiology of these two related conditions.
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